Showing results (101-110 of 154) with videos related to

Sort By:
Pageof 16
Internal Medicine (Tokyo, Japan)|June 13, 2012
Retrospective comparison of the efficacy of tonsillectomy with and without steroid-pulse therapy in IgA nephropathy patientsNaoki Nakagawa, Maki Kabara, Motoki Matsuki, et al.
Cancer Immunology, Immunotherapy : CII|March 11, 2015
CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphomaTakumi Kumai, Toshihiro Nagato, Hiroya Kobayashi, et al.
Laryngoscope Investigative Otolaryngology|December 22, 2022
The efficacy of PD-1 inhibitors in patients with salivary gland carcinoma: A retrospective observational studyRyosuke Sato, Takumi Kumai, Yoshiya Ishida, et al.
Scientific Reports|November 6, 2015
Targeting HER-3 to elicit antitumor helper T cells against head and neck squamous cell carcinomaTakumi Kumai, Takayuki Ohkuri, Toshihiro Nagato, et al.
Cancer Research|February 5, 2008
Induction of EBV-latent membrane protein 1-specific MHC class II-restricted T-cell responses against natural killer lymphoma cellsHiroya Kobayashi, Toshihiro Nagato, Miki Takahara, et al.
Oncoimmunology|May 8, 2015
c-Met is a novel tumor associated antigen for T-cell based immunotherapy against NK/T cell lymphomaTakumi Kumai, Yoshinari Matsuda, Takayuki Ohkuri, et al.
Head and Neck Pathology|September 13, 2018
Glomangiopericytoma of the Nasal Cavity with CTNNB1 p.S37C Mutation: A Case Report and Literature ReviewMichihisa Kono, Nobuyuki Bandoh, Ryosuke Matsuoka, et al.
Cancer Immunology Research|February 28, 2018
Sustained Persistence of IL2 Signaling Enhances the Antitumor Effect of Peptide Vaccines through T-cell Expansion and Preventing PD-1 InhibitionHussein Sultan, Takumi Kumai, Valentyna I Fesenkova, et al.
The Laryngoscope|July 3, 2009
Rehabilitation of bilaterally paralyzed canine larynx with implantable stimulatorDavid L Zealear, Isamu Kunibe, Kenichiro Nomura, et al.
Cancer Immunology, Immunotherapy : CII|March 18, 2014
Induction of tumor-reactive T helper responses by a posttranslational modified epitope from tumor protein p53Takumi Kumai, Kei Ishibashi, Kensuke Oikawa, et al.
Pageof 16